No results for ‘’
Kabra Drugs Ltd
₹20.78
(3.18%)
Fri, 18 Sept 2026, 04:01 am
Health Technology
Pharmaceuticals: Generic
24.5KKabra Drugs Enterprise Value (EV)
No Result Found
| Particulars |
|---|
| Price to earnings ratio |
| Price to book ratio |
| Price to sales ratio |
| Price to cash flow ratio |
| Enterprise value |
| Enterprise value to EBITDA ratio |
| Debt to equity ratio |
| Return on equity % |
Kabra Drugs Ltd Enterprise Value
The Kabra Drugs Ltd Enterprise Value is a key financial metric used by investors to evaluate Kabra Drugs Ltd's valuation, profitability, and overall financial performance. Tracking the Kabra Drugs Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Kabra Drugs Ltd (NSE: , BSE: 524322) is currently trading at ₹20.78, with a market capitalization of ₹0. As a leading company in the Health technology sector and Pharmaceuticals: generic industry, monitoring the Kabra Drugs Ltd Enterprise Value is essential for fundamental analysis.
Kabra Drugs Ltd Enterprise Value Current Value
The current Kabra Drugs Ltd Enterprise Value stands at 0.
The Kabra Drugs Ltd Enterprise Value remains stable, indicating consistent financial performance.
Kabra Drugs Ltd Enterprise Value Historical Trend
The Kabra Drugs Ltd Enterprise Value has shown the following historical trend:
The decline in Kabra Drugs Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Kabra Drugs Ltd Enterprise Value Indicates for Investors
The Kabra Drugs Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Kabra Drugs Ltd.
Kabra Drugs Ltd Enterprise Value Analysis Summary
The Kabra Drugs Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Kabra Drugs Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Kabra Drugs Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.